During the past decade, Clínica Universitaria Reina Fabiola conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clínica Universitaria Reina Fabiola" #1 sponsor was "Pfizer" with 3 trials, followed by "Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Universitaria Reina Fabiola" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Clínica Universitaria Reina Fabiola" are "Breast Cancer" (2 trials), "Acute Diverticulitis" (1 trials), "Antiphospholipid Syndrome" (1 trials), "Arterial Thrombosis" (1 trials) and "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Clínica Universitaria Reina Fabiola" in a lesser frequency.

Most popular intervention types in "Clínica Universitaria Reina Fabiola" are "Drug" (19 trials), "Biological" (3 trials), "Genetic" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Cetuximab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Universitaria Reina Fabiola" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clínica Universitaria Reina Fabiola". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clínica Universitaria Reina Fabiola, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Universitaria Reina Fabiola, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".